Connection

Fernando Bozza to Vero Cells

Back to Details
This is a "connection" page, showing publications Fernando Bozza has written about Vero Cells.
Fernando Bozza
Connection Strength
0.078
Vero Cells
  1. In vitro antiviral activity of the anti-HCV drugs daclatasvir and sofosbuvir against SARS-CoV-2, the aetiological agent of COVID-19. J Antimicrob Chemother. 2021 06 18; 76(7):1874-1885.
    View in: PubMed
    Score: 0.017
  2. Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators. PLoS Pathog. 2020 12; 16(12):e1009127.
    View in: PubMed
    Score: 0.017
  3. Atazanavir, Alone or in Combination with Ritonavir, Inhibits SARS-CoV-2 Replication and Proinflammatory Cytokine Production. Antimicrob Agents Chemother. 2020 09 21; 64(10).
    View in: PubMed
    Score: 0.016
  4. Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo. PLoS Negl Trop Dis. 2019 01; 13(1):e0007072.
    View in: PubMed
    Score: 0.015
  5. Sofosbuvir protects Zika virus-infected mice from mortality, preventing short- and long-term sequelae. Sci Rep. 2017 08 25; 7(1):9409.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.